Chemokines: progress toward identifying molecular targets for therapeutic agents.
about
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundleCloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cellsMonocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10)Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw.Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III.Actions of heparin that may affect the malignant process.Chemoattractant receptor cross-desensitization.The equine herpesvirus 2 E1 open reading frame encodes a functional chemokine receptor.beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruziChemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.Vitamin A modifies the intestinal chemokine and cytokine responses to norovirus infection in Mexican childrenThe intricate role of CXCR4 in cancer.Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration.Visualization of chemokine binding sites on human brain microvesselsThe chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffoldIn vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II.Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes.Pathogenesis of atherosclerosis: A multifactorial process.A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.Current status and challenges of cytokine pharmacology.The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.Activation of the 9E3/cCAF chemokine by phorbol esters occurs via multiple signal transduction pathways that converge to MEK1/ERK2 and activate the Elk1 transcription factor.trans-Retinoic acid blocks platelet-derived growth factor-BB-induced expression of the murine monocyte chemoattractant-1 gene by blocking the assembly of a promoter proximal Sp1 binding site.Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat.Mechanisms affecting neutrophil migration capacity in breast cancer patients before and after chemotherapy.Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase.Assay of OAZ1 mRNA levels in chronic myeloid leukemia combined with application of leukemia PCR array identified relevant gene changes affected by antizyme.Upregulation of the chemokines Rantes, MCP-1, MIP-1a and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen.Phenotypic features of innate and adaptive immunity in patients with chronic hepatitis C and end-stage renal disease.Immunohistochemical distinction of metastases of renal cell carcinoma with molecular analysis of overexpression of the chemokines CXCR2 and CXCR3 as independent positive prognostic factors for the tumorigenesis.
P2860
Q22253922-9FC3065F-BEA2-43B6-AB24-B284E0F924D2Q24652902-9BE9CF98-00C3-46AA-8A6C-118383C07862Q24685890-DB0A8578-6166-4753-B255-A7EBEF04E85AQ27629348-954F2753-25A9-4158-8FCB-90761D5A2505Q31951482-7E944D4A-0D34-491B-8382-D0B18F913954Q33335794-683E0347-141E-4B8F-B568-E9CDB0FD6CBAQ33534337-71133895-AB91-4293-A121-BEF74C95CC10Q33536432-375B7B41-1B36-4329-8B9F-86C2C15AB0BFQ33824585-5BF1C77F-DAEA-495A-B712-B5DB413C2871Q34001865-827BDCA6-FE6B-4D8C-AC10-E9FEE238A585Q34231598-45394C42-16E0-4C7D-9489-EF79AE4EB856Q34802923-48773051-AA82-44AA-8CF5-B12E8F342679Q35067624-23337E51-BE6B-4A44-AEFD-DA8C6745E6BCQ35786830-91BAB216-4B5C-4666-AE73-1D83A886C5D6Q35908535-4C3F22CF-2139-4A0B-BB65-19092C835E4BQ36256452-40CDB113-E83E-49FE-B735-78469F11705DQ36447255-CABCCA4D-5B14-4BE4-AEC9-7EFA8D3791CFQ36631409-2C934F87-EAAB-4505-90D5-5DC1FDA8B1D8Q36851771-B3EDF530-A061-4FAA-BB8A-13BB974B00E7Q37024745-459B3986-BFE6-4FFF-9085-DC0ADC521D95Q37276377-1F587736-B4D9-4130-BE68-2833073BC573Q37377448-2E06E969-CC11-4017-9824-82E94F466A68Q37445966-2D04589F-3007-4CB9-9F0A-9209CA7A6896Q39009977-54B93A34-9FD0-4420-A60C-EEF21A25649BQ41666458-3FED028C-0829-4745-960F-406054B0D5FDQ42809278-18B08CF7-27AD-4A34-A57D-39D34932DF81Q43634198-617F6CD2-9449-4261-AA5B-E9146CD2F044Q44485049-81A3FF2F-C721-4B40-8C8F-3369363EEA2AQ44630332-BD03FC41-3956-43C7-93F2-21AB59316E1AQ45184366-8CEC38C5-D7F9-4302-BFA5-4F17505DA582Q45221347-3FA2DD22-7B17-419D-ADCE-53FDF5981867Q46365132-03F07158-0334-411F-9C62-A1074C4A6F40Q51714575-F4DE9365-2D53-43CB-AC40-6C5F8B052B87
P2860
Chemokines: progress toward identifying molecular targets for therapeutic agents.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Chemokines: progress toward identifying molecular targets for therapeutic agents.
@en
type
label
Chemokines: progress toward identifying molecular targets for therapeutic agents.
@en
prefLabel
Chemokines: progress toward identifying molecular targets for therapeutic agents.
@en
P1476
Chemokines: progress toward identifying molecular targets for therapeutic agents.
@en
P2093
Ben-Baruch A
Oppenheim JJ
P356
10.1016/0167-7799(96)80920-6
P50
P577
1996-02-01T00:00:00Z